SOURCE: Alpharma Inc.

April 29, 2008 17:23 ET

Alpharma Announces Information for First Quarter 2008 Earnings Conference Call

BRIDGEWATER, NJ--(Marketwire - April 29, 2008) - Alpharma Inc. (NYSE: ALO) announced that the company will release its first quarter 2008 earnings before the market opens on Monday, May 5, 2008. Alpharma's management will conduct a conference call / webcast on Monday, May 5, 2008 beginning at 8:30 AM Eastern Daylight Time to discuss its first quarter results. The presentation, which management will refer to on the call, will be available on the company's website in the "Investor's Support" section at

The call will be open to all interested parties and may be accessed by using the following information:

                        CONFERENCE CALL ACCESS
               Domestic Dial In:       (800) 351-4892
               International Dial In:  (334) 323-7224
               Conference Call ID:     ALPHARMA

Investors can access the call in a "listen only" mode via the Internet at

In addition, for those unable to participate at the time of the call, a rebroadcast will be available following the call from Monday, May 5, 2008 at 12:00 PM Eastern Daylight Time until midnight, Monday, May 19, 2008 Eastern Daylight Time. The rebroadcast may be accessed on the Internet at or by telephone using the following information:

                         REBROADCAST ACCESS
               Domestic Dial In:       (877) 919-4059
               International Dial In:  (334) 323-7226
               Participant Code:       94596047

About Alpharma

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 80 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and the FLECTOR® Patch (diclofenac epolamine topical patch). In addition, Alpharma is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Alpharma press releases are also available at our website.

Contact Information

  • Contact:
    Jack Howarth
    Vice President, Investor Relations
    Email Contact